Omer Birkan Agrali*,
Yaprak Kalkan, Leyla Kuru
Department of Periodontology, Faculty of Dentistry, Marmara University,
Istanbul, Turkey
*Corresponding author: Omer Birkan
Agrali, Department of Periodontology, Faculty of Dentistry, Marmara University,
Istanbul, Turkey. Tel: +9002164211621; E-mail: omer.agrali@marmara.edu.tr
Received Date: 27 July, 2017; Accepted Date: 05 August, 2017; Published Date: 11
August, 2017
1. Introduction
Periodontitis is characterized by clinical attachment
loss and formation of osseous deformities around teeth [1]. The ultimate goal of periodontal therapy is the reconstitution
of lost periodontal tissues and function through regeneration of the attachment
apparatus [2]. There are several different
materials and approaches used for the periodontal regeneration of intrabony
defects. Platelet Rich Fibrin (PRF) which is a composition of various growth
factors such as platelet-derived growth factor, basic fibroblast growth factor,
transforming growth factor, vascular endothelial growth factor, insulin-like
growth factor, and epidermal growth factor has a potential to regenerate
periodontal tissues as a healing matrix [3]. It
has been demonstrated that PRF in combination with Bovine Derived Xenograft
(BDX) has ability to increase the regenerative effects in intrabony defects [4]. The aim of this report is to present the effect
of PRF+BDX combination in the treatment of human intrabony periodontal defects.
2. Description of the Case
Periodontal treatment of a 40-year-old systemically
healthy non-smoker female chronic periodontitis patient who is on a supportive
periodontal treatment program at Marmara University Department of
Periodontology Clinic was presented. Initial clinical measurements are 5 mm Probing
Depth (PD) at the mesial site of tooth 43; 5 mm PD at the distal site and 9 mm
PD at the mesial site of tooth 42; and 10 mm PD at the distal site of tooth 41
(Figure 1a, b) with the radiographic evidence of
bone loss (Figure 1c). Regenerative periodontal
surgery was planned for the treatment of these sites by using of PRF+BDX.
3. Treatment Procedure
After local infiltrative anesthesia, a full thickness
flap was raised with the sulcular incision (Figure 2a),
and the granulation tissue was removed from the inner surface of the flap. Root
surfaces were planed using hand instruments and ultrasonic scaler. Intrabony
defects were detected at the distal site of #41, mesial and distal sites of the
#42, mesial site of the #43 (Figure 2b,c). 10 ml
venous blood was collected from the ante-cubital vein and placed in the
centrifuge before surgery. After 12 min of centrifugation at 2700 rpm, the
middle (platelet rich) layer of the concentrate was separated (Figure 3a,b,c). The PRF box, which separates serum
from fibrin was used to obtain a stable form (Figure
3d). Intrabony defects were filled with BDX (BioOss®, Geistlich)+PRF combination (Figure 2d). Additionally, PRF was used for covering
the graft material (Figure 3e,f). Only one PRF layer was
used in the interdental area in order to cover the graft material and also
added one more PRF layer each on the buccal and oral sides of the defects. Polyglycolide-co-lactide 4.0 braided, (Pagelak®, Dogsan, Trabzon, Turkey), synthetic,
absorbable, multifilament surgical suture material was used for closuring the
flap. Non-steroidal
anti-inflammatory drugs and wide-spectrum antibiotics were administered twice a
day postoperatively for 10 days. In addition, 0.2% chlorhexidine digluconate
containing mouth rinse was prescribed for 15 days. Sutures were removed 15 days
after the intervention (Figure 4). No
complications were observed other than normal levels of postsurgical pain and
swelling. Patient had regular recall controls with 3 months intervals.
4. Treatment outcomes
At 9 months, there were considerable clinical (Figure 5a,b,c) and radiographic (Figure 5d) improve ments in PD and clinical attachment
level parameters. A 3 mm decrease in PD and 3 mm Attachment Gain (AG) at the
mesial site of tooth 43; 3 mm PD decrease and 2 mm AG at the distal site of
tooth 42; 7 mm PD decrease and 5 mm AG at the mesial site of tooth 42; and 9 mm
PD decrease and 8 mm AG at the distal site of tooth 41 were observed (Table 1).
5. Discussion
This case demonstrates the positive effect of
regenerative periodontal treatment approach in deep intrabony periodontal
defects. Patient compliance is essential for short and long-term success of
periodontal therapy [5,6]. In this case, good
compliance and satisfactory oral hygiene maintenance were provided by the
patient during the observation period. As a risk factor smoking modifies the
periodontal response to the microbial activity and results in increase the
amount of tissue lost in periodontal diseases [7,8].
Our patient was not a smoker so that this also enhanced the healing response.
Similarly, occlusal trauma causes periodontal disease activity to reoccur and uncontrolled
the inflammation [9] and it is not possible to
regenerate bone under this active inflammation [10].
In this case occlusal contacts were eliminated in the related region before
periodontal flap operation. As a regenerative biomaterial, PRF preparation does
not require the use of any anti-clotting agent compared with other platelet
concentrates, such as Platelet Rich Plasma (PRP) [11].
The naturally forming PRF containing platelet and leukocytes clot has a dense
and complex structure. It can be thought that this dense framework provides
protection of growth factors from proteolysis and slower/sustained release of
growth factors into the wound area [12]. It is
easier and cheaper to prepare PRF, and also less risky to the patients [13,14]. Also, it is shown that the use of PRF with
bone mineral matrix has the ability to increase the regenerative capacity in intrabony
periodontal defects [4]. Under the light of
these evidences, we preferred the use of xenograft (BIO-OSS™; Geistlich, Switzerland), hypothesizing that
it could enhance the space maintaining for tissue regeneration and also
stimulate cells for bone filling. PRF was also used as a biological membrane
onto xenograft as suggested by Panda et al. [15] who
used minced PRF+ xenograft combination in intrabony defects. The reason of
choosing minced PRF was reported as easy manipulation and delivery to the surgical
sites. In this case report, the reduction in PD and gain CAL were evaluated
after 6 months of follow-up period. At the end of 9 months promising clinical
and radiographic results were obtained in our case report. AG scores of this
case were similar with the case of Panda et al. [15].
Today with the help of various numbers of technologic systems, biological
approaches and biomaterials facilitate and contribute patient outcomes in terms
of function, ease of care, aesthetics and long-term maintenance. A recent
review demonstrating results of different regenerative approaches conducted in
the intrabony periodontal defects suggested similar results with our case [16]. Within the limits, following conclusions can be
made: The use of PRF with bone graft materials is helpful for periodontal
regenerative treatment. Positive clinical outcome is based on:
•
Reduction in
PD.
•
Gain in CAL.
•
Radiographic
defect fill.
•
Improved
patient function and comfort.

Figure 1(a-c): Clinical (a,b) and radiographic
(c) view at the baseline.

Figure
2(a-d): Sulcular
incision (a), clinical view of the intrabony defects (c,d), application of the
graft material into the defects.

Figure
3(a-f): Preparation (a,b,c,d) and application (d,f) of PRF.

Figure 4(a-c): Suturing during surgery
(a), postoperative 15 days (b), removing sutures i15 days after surgery (c).

Figure
5(a-d): Clinical
(a,b,c) and radiographic (d) views 9 months after surgery.
| |
#43
mesial
0.day
|
#43 mesial
9.month
|
#42
distal
0.day
|
#42
distal
9.month
|
#42
mesial
0.day
|
#42 mesial
9.month
|
#41
distal
0.day
|
#41 distal
9.month
|
|
PD
(mm)
|
5
|
2
|
5
|
2
|
9
|
2
|
10
|
1
|
|
GR
(mm)
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
4
|
|
CAL
(mm)
|
5
|
2
|
5
|
3
|
10
|
5
|
13
|
5
|
|
PD: Pocket Depth, GR: Gingival Recession, CAL: Clinical Attachment Level
|
Table 1: Changes in the periodontal parameters.
1.
Graziani F, Gennai S, Cei
S, Cairo F, Baggiani A, et al. (2012) Clinical performance of access flap
surgery in the treatment of the intrabony defect. A systematic review and
meta-analysis of randomized clinical trials. J Clin Periodontol 39: 145-156.
2.
Bowers GM, Schallhorn RG,
Mellonig JT (1982) Histologic evaluation of new attachment in human intrabony
defects. A literature review. J Periodontol 53: 509-514.
3.
Hantash BM, Zhao L, Knowles
JA, Lorenz HP (2008) Adult and fetal wound healing. Front Biosci 13: 51-61.
4.
Lekovic V, Milinkovic I,
Aleksic Z, Jankovic S, Stankovic P, et al. (2012) Platelet-rich fibrin and
bovine porous bone mineral vs. platelet-rich fibrin in the treatment of
intrabony periodontal defects. J Periodontal Res 47: 409-417.
5.
Zeza B, Pilloni A, Tatakis
DN, Mariotti A, Di Tanna G, et al. (2017) Implant Patient Compliance Varies by
Periodontal Treatment History. J Periodontol 9: 1-13.
6.
Perrell-Jones C, Ireland RS
(2016) What factors influence patient compliance with supportive periodontal
therapy in a general practice setting? Br Dent J 221: 701-704.
7.
Schei
O, Waerhaug J, Lovdal A, Arno A (1959) Alveolar bone loss as related to oral
hygiene and age. Journal of Periodontology 30: 7-16.
8.
Calsina G, Ramón JM, Echeverría JJ (2002)
Effects of smoking on periodontal tissues. J Clin Periodontol 29: 771-776.
9.
Reinhardt RA, Killeen AC
(2015) Do mobility and Occlusal trauma impact periodontal longevity? Dent Clin North Am 59:
873-883.
10.
Kantor M, Polson AM, Zander
HA (1976) Alveolar bone regeneration after removal of inflammatory and
traumatic factors. J Periodontol 47: 687-695.
11.
Dohan DM, Choukroun J, Diss
A, Dohan SL, Dohan AJ (2006) Platelet-Rich Fibrin (PRF): a second-generation
platelet concentrate. Part I: technological concepts and evolution. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod 101: 37-44.
12.
Lundquist R, Dziegiel MH,
Agren MS (2008) Bioactivity and stability of endogenous fibrogenic factors in
platelet-rich fibrin. Wound Repair Regen 16: 356-363.
13.
Dohan DM, Choukroun J, Diss
A, Dohan SL, Dohan AJ, et al. (2006) Platelet-Rich Fibrin (PRF): a
second-generation platelet concentrate. Part III: leucocyte activation: a new
feature for platelet concentrates?.Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 101: 51-55.
14.
Dohan DM, Choukroun J, Diss
A, Dohan SL, Dohan AJ, et al. (2006) Platelet-Rich Fibrin (PRF): a
second-generation platelet concentrate. Part II: platelet-related biologic
features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101: 45-50.
15.
Panda S, Jayakumar ND,
Sankari M, Varghese SS, Kumar DS (2014) Platelet rich fibrin and xenograft in
treatment of intrabony defect. Contemp Clin Dent 5: 550-554.
16.
Miron RJ, Zucchelli G,
Pikos MA, Salama M, Lee S, et al. (2017) Use of platelet-rich fibrin in
regenerative dentistry: a systematic review. Clin Oral Investig 21: 1913-1927.